⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HELP News
Cybin Inc. Common Stock
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
prnewswire.com
GHRS
HELP
DFTX
ATAI
CMPS
LLY
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
globenewswire.com
HELP
DFTX
CMPS
GHRS
JNJ
Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
globenewswire.com
HELP
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
prnewswire.com
GHRS
HELP
DFTX
CMPS
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
globenewswire.com
HELP
Helus Pharma™ Announces US$50 Million Underwritten Offering
globenewswire.com
HELP
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
globenewswire.com
HELP
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
globenewswire.com
HELP
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
globenewswire.com
HELP
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
globenewswire.com
HELP